Krka d d : 2021 Supervisory Board Report of Krka, d. d., Novo mesto
April 14, 2022 at 07:35 am EDT
Share
INI-199/22
KRKA, d. d., Novo mesto
2021 Supervisory Board Report of Krka, d. d., Novo mesto
Based on the provisions of the Rules of the Ljubljana Stock Exchange, d. d., Ljubljana and Article 134 of the Market in Financial Instruments Act, Krka, d. d., Novo mesto publishes the 2021 Supervisory Board Report of Krka, d. d., Novo mesto.
The report will be published on the Company's website (www.krka.biz) from 14 April 2022 onwards, for a period of at least 10 years.
Krka, d. d., Novo mesto
Date: 14.04.2022
Attachments:2021 Supervisory Board Report of Krka, d. d., Novo mesto
Attachments
Original Link
Original Document
Permalink
Disclaimer
KRKA dd published this content on 14 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 April 2022 11:34:08 UTC.
Krka dd Novo Mesto is a Slovenia-based company engaged in the production of pharmaceutical preparations. The Company operates through four segments: Prescription Pharmaceuticals that includes medicines for the treatment of cardiovascular diseases, alimentary tract and metabolism and drugs for diseases of the central nervous system, among others; Non-prescription Products, providing vitamins and minerals, cough and cold products, analgesics, sore throat products, among others; Animal Health Products, which offers general anti-infectives and antiparasitics for animals; Health Resort and Tourist Services consisting of Spa resorts in Smarjeske Toplice, Dolenjske Toplice, Strunjan, Novo Mesto and Otocec. Krka dd Novo Mesto is a controlling company of the Krka Group that includes two subsidiaries in Slovenia, Terme Krka doo and Farma GRS doo, and over 20 subsidiaries abroad in such countries as Croatia, Germany, Sweden, Poland, Spain, United States, Ireland, among others.
KRKA, D. D. 
